Characterizing the Disease-Initiating Cell Population In a Murine Model of Jak2V617F+Myeloproliferative Neoplasm

被引：0
|
作者：
Mullally, Ann
Lane, Steven W. [2 ]
Poveromo, Luke
Al-Shahrour, Fatima
Kutok, Jeffery [1 ]
Ebert, Benjamin L. [3 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[2] Childrens Hosp, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：144 / 145
页数：2
相关论文
共 50 条
  • [1] Limited Efficacy of BMS-911543 in a Murine Model of JAK2V617F Myeloproliferative Neoplasm
    Pomicter, Anthony D.
    Eiring, Anna M.
    Senina, Anna V.
    Marvin, James E.
    Prchal, Josef T.
    O'Hare, Thomas
    Deininger, Michael W.
    BLOOD, 2014, 124 (21)
  • [2] JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm
    Lee, Sandy
    Wong, Helen
    Castiglione, Melissa
    Murphy, Malea
    Kaushansky, Kenneth
    Zhan, Huichun
    STEM CELLS, 2022, 40 (04) : 359 - 370
  • [3] JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm
    Lee, Sandy
    Wong, Helen
    Castiglione, Melissa
    Murphy, Malea
    Kaushansky, Kenneth
    Zhan, Huichun
    BLOOD, 2021, 138
  • [4] Characterization of murine JAK2V617F-positive myeloproliferative disease
    Bumm, Thomas G. P.
    Elsea, Collin
    Corbin, Amie S.
    Loriaux, Marc
    Sherbenou, Daniel
    Wood, Lisa
    Deininger, Jutta
    Silver, Richard T.
    Druker, Brian J.
    Deininger, Michael W. N.
    CANCER RESEARCH, 2006, 66 (23) : 11156 - 11165
  • [5] JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines
    Nauroy, P.
    Delhommeau, F.
    Baklouti, F.
    BLOOD CANCER JOURNAL, 2014, 4 : e222 - e222
  • [6] JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines
    P Nauroy
    F Delhommeau
    F Baklouti
    Blood Cancer Journal, 2014, 4 : e222 - e222
  • [7] The Thrombopoietin Receptor, MPL, Is Critical for the Development of JAK2V617F-Induced Cardiovascular Disease in a Murine Model of Myeloproliferative Neoplasm
    Zhang, Haotian
    Zhan, Huichun
    BLOOD, 2022, 140 : 3848 - 3849
  • [8] Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm
    Castiglione, Melissa
    Zhang, Haotian
    Kaushansky, Kenneth
    Zhan, Huichun
    EXPERIMENTAL HEMATOLOGY, 2021, 100 : 52 - 62
  • [9] Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm
    Castiglione, Melissa
    Jiang, Ya-Ping
    Mazzeo, Christopher
    Lee, Sandy
    Chen, Juei-Suei
    Kaushansky, Kenneth
    Yin, Wei
    Lin, Richard Z.
    Zheng, Haoyi
    Zhan, Huichun
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (12) : 3359 - 3370
  • [10] Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm
    Lamrani, Lamia
    Lacout, Catherine
    Ollivier, Veronique
    Denis, Cecile V.
    Gardiner, Elizabeth
    Noe, Benoit Ho Tin
    Vainchenker, William
    Villeval, Jean-Luc
    Jandrot-Perrus, Martine
    BLOOD, 2014, 124 (07) : 1136 - 1145
12345